AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction

Area of Science:

• Cardiovascular Biology
• Metabolic Regulation
• Aging Research

Background:

• Aging is linked to myocardial dysfunction, but the mechanisms remain unclear.
• AMP-activated protein kinase (AMPK), a crucial energy sensor, declines with age.
• This decline may contribute to age-related heart problems.

Purpose of the Study:

• To investigate the role of AMPK deficiency in aging-associated myocardial dysfunction.
• To determine how AMPK impacts cardiac function, mitochondrial health, and oxidative stress during aging.

Main Methods:

• Used young and old wild-type (WT) and AMPK kinase-dead (KD) transgenic mice.
• Assessed AMPK activity, cardiac function, morphology, and mitochondrial parameters (ROS, mitochondrial membrane potential).
• Utilized techniques including histology, electron microscopy, and immunoblotting.

Main Results:

• AMPK deficiency worsened aging-related decreases in cardiomyocyte function and SERCA2a levels.
• Aged KD mice showed exacerbated cardiac hypertrophy, mitochondrial damage, and increased ROS production.
• AMPK deficiency reduced PGC-1alpha, Glut4, and HSP90 expression, while metformin improved cardiac function.

Conclusions:

• AMPK deficiency plays a significant role in aging-induced cardiac dysfunction.
• Disrupted mitochondrial function and increased ROS production are likely mechanisms.
• Targeting AMPK with activators like metformin may offer therapeutic benefits for age-related heart disease.